AlphaQuest’s iTeos Therapeutics ITOS Stock Holding History

AlphaQuest’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29,019	Closed	-$289K	–	2259
2025 Q2	$289K	Sell	29,019 -1,728	-6%	-$13.9K	0.03%	902
2025 Q1	$184K	Sell	30,747 -10,571	-26%	-$77.6K	0.02%	1039
2024 Q4	$317K	Buy	41,318 +30,298	+275%	+$260K	0.04%	683
2024 Q3	$113K	Buy	11,020 +9,934	+915%	+$152K	0.01%	1257
2024 Q2	$16.1K	Sell	1,086 -711	-40%	-$10.2K	﹤0.01%	1302
2024 Q1	$24.5K	Sell	1,797 -6,439	-78%	-$70.2K	﹤0.01%	1014
2023 Q4	$90.2K	Buy	+8,236	New	+$81.6K	0.02%	785

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AlphaQuest's ITOS Position: Q3 2025 in Review

AlphaQuest sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 29,019 shares — an estimated $289K sold.

AlphaQuest first reported a position in ITOS in Q4 2023 and held it in 7 quarters. The position peaked at $317K in Q4 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

AlphaQuest reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
AlphaQuest sold 29,019 iTeos Therapeutics shares in Q3 2025, an estimated $289K.
AlphaQuest first reported a position in iTeos Therapeutics in Q4 2023 and held it in 7 quarters.
AlphaQuest's iTeos Therapeutics position peaked at $317K in Q4 2024.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on AlphaQuest's 13F filing for Q3 2025, filed 3 Nov 2025.